Register for our free email digests:
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Want to know more about medtech regulatory efforts in countries from Singapore to Myanmar to Russia, and more in between? In this week's podcast, Ashley Yeo provides an update from his reporting on what governments in the Asia and Eurasia regions are doing to focus oversight on devices and diagnostics. The short answer: A lot.
In this week's Device Week podcast, we look at recent mergers and acquisitions. While the year started out slow, July was the busiest month for medtech M&A deals. At this rate the industry is set to break last year's deal count. We go in-depth into some of the major deals, and more.
With earnings season in full swing, Tina Tan and Reed Miller of Medtech Insight review the performances of companies across the orthopedics sector and throw the spotlight on some big medtech pureplays and diversified health care firms.
In this week's podcast, Medtech Insight journalists discuss what was a busy week in Washington, DC: The health-care failure on Capitol Hill, and what it means for medtech; FDA's new plan for digital health; and one case to watch during the US Supreme Court's next term.
On this week's Medtech Insight podcast: US Senate passes $2.8bn FDA spending bill; US approvals and clearances strong in first six months of 2017; the global heart-valve repair and replacement devices market is highlighted.
On this week's Medtech Insight podcast: FDARA user-fee bill progresses in the US Congress; a deep-dive look into the US Open Payments database yields interesting news and trends; in an unusual step, US FDA publicly shares 483 inspection observation form after troublesome Magellan Diagnostics audit; standards organization GS1 and the Healthcare Industry Distributors Association try to solve billing headaches; top management shaken up at Zimmer Biomet.
On this week's Medtech Insight podcast: supply-chain oversight program MedAccred makes a splash in industry; first diagnostic to use flow cytometry to detect rare blood cancers wins US FDA clearance; Ethicon sues Intuitive over surgical tool patents; Konica Minolta snaps up Ambry Genetics for $1bn; “Petya” and “Wannacry” ransomware attacks concern industry; a Thermo Fisher leader talks with Medtech Insight about the regulatory experience surrounding its Oncomine Dx Target Test.
On this week's 100th Medtech Insight podcast: a new value-based reimbursement scheme emerges between Medtronic and Aetna; a major escalation in cybersecurity threats to medical devices concerns industry; the US Senate plans to keep the device tax repeal in its reworked health-care bill; a look at US FDA funding; two innovative device companies are spotlighted; medtech legal advocates want to bring FDA’s 510(k) process before the Supreme Court; virtual reality therapy gains traction.
On this week's Medtech Insight podcast: US congressional hearing highlights India’s efforts to place price caps on foreign-made devices; Senate health-care bill nixes device tax; Costa Rican quality control experts lean on each other for industry education; US FDA issues a draft guidance on electronic records and signatures.
On this week's Medtech Insight podcast: expect digital health guidance documents from US FDA soon, the agency’s commissioner says; FDA optimistic it will push out a final version of a 3D printing manufacturing guidance this year; US government releases data on the number of people who would lose health insurance under the American Health Care Act; Wells Fargo report fingers which device types would be most impacted by Trumpcare; a look at FDA approval and clearance trends, including a noticeable increase in 510(k)s; new clinical data releases discussed.
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.